Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Glioblastoma multiforme		Acetylation	N	S2	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Uterine corpus endometrial carcinoma		Acetylation	N	S2	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Glioblastoma multiforme		Phosphorylation	N	S2	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Uterine corpus endometrial carcinoma		Phosphorylation	N	S2	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Glioblastoma multiforme		Phosphorylation	N	T6	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Hepatocellular carcinoma		Phosphorylation	N	T6	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Uterine corpus endometrial carcinoma		Phosphorylation	N	T6	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Acetylation	N	K91	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Acetylation	N	K91	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Acetylation	N	K128	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Stomach adenocarcinoma		Acetylation	N	K128	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Uterine carcinosarcoma		Acetylation	N	K128	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Ubiquitination	N	K128	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Stomach adenocarcinoma		Ubiquitination	N	K128	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Uterine carcinosarcoma		Ubiquitination	N	K128	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Blastoma		Acetylation	N	K252	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Liver cancer		Acetylation	N	K252	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Acetylation	N	K252	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Uterine corpus endometrial carcinoma		Acetylation	N	K252	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Bladder urothelial carcinoma		Phosphorylation	N	T267	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Phosphorylation	N	Y316	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Skin cutaneous melanoma		Phosphorylation	N	T337	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Skin cutaneous melanoma		Phosphorylation	N	T341	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Skin cancer		Acetylation	N	K353	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Phosphorylation	N	S360	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Acetylation	N	K367	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Bladder urothelial carcinoma		Ubiquitination	N	K398	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Colon adenocarcinoma		Ubiquitination	N	K398	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Lung adenocarcinoma		Ubiquitination	N	K398	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Pancreatic cancer		Phosphorylation	N	S413	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Prostate cancer		Phosphorylation	N	S413	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Esophageal cancer		Acetylation	N	K435	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Bladder urothelial carcinoma		Phosphorylation	N	Y481	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Bladder urothelial carcinoma		Ubiquitination	N	K490	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	T493	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Breast invasive carcinoma		Acetylation	N	K495	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Acetylation	N	K495	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Breast invasive carcinoma		Ubiquitination	N	K495	
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K495	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Breast invasive carcinoma		Phosphorylation	N	S2	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Breast cancer		Phosphorylation	N	S4	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Breast invasive carcinoma		Phosphorylation	N	S4	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Breast invasive carcinoma		Ubiquitination	N	K6	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Breast invasive carcinoma		Acetylation	N	K11	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Breast invasive carcinoma		Ubiquitination	N	K11	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Head and neck squamous cell carcinoma		Acetylation	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Male infertility		Acetylation	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Head and neck squamous cell carcinoma		Methylation	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Male infertility		Methylation	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Head and neck squamous cell carcinoma		SUMOylation	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Male infertility		SUMOylation	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Head and neck squamous cell carcinoma		Ubiquitination	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Male infertility		Ubiquitination	N	K30	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Head and neck squamous cell carcinoma		Phosphorylation	N	T35	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Male infertility		Phosphorylation	N	T35	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Head and neck squamous cell carcinoma		Methylation	N	R39	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K41	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S46	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K48	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K48	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Hepatocellular carcinoma		Phosphorylation	N	S62	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K75	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K75	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	Y76	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S77	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K86	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K86	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	C	S87	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S87	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Pancreatic adenocarcinoma		Acetylation	N	K91	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K91	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Pancreatic adenocarcinoma		Ubiquitination	N	K91	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K91	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Pancreatic adenocarcinoma		Acetylation	N	K97	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Pancreatic cancer		Acetylation	N	K97	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Pancreatic adenocarcinoma		Ubiquitination	N	K97	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Phosphorylation	N	S115	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Brain lower grade glioma		Methylation	N	R123	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Methylation	N	R123	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Brain lower grade glioma		Acetylation	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Acetylation	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Melanoma		Acetylation	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Acetylation	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Brain lower grade glioma		Ubiquitination	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Melanoma		Ubiquitination	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Ubiquitination	N	K131	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Acetylation	N	K133	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Melanoma		Acetylation	N	K133	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Acetylation	N	K133	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S136	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Melanoma		Phosphorylation	N	S136	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Phosphorylation	N	S136	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Melanoma		Ubiquitination	N	K139	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Ubiquitination	N	K139	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Melanoma		Acetylation	N	K141	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Acetylation	N	K141	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Melanoma		Ubiquitination	N	K141	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Ubiquitination	N	K141	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Glioblastoma multiforme		Phosphorylation	N	S153	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S153	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S155	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Glioblastoma multiforme		Acetylation	N	K156	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K156	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Glioblastoma multiforme		Ubiquitination	N	K156	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K156	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	C	Y161	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Glioblastoma multiforme		Phosphorylation	N	Y161	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	Y161	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	T168	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Bladder urothelial carcinoma		Ubiquitination	N	K184	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Methylation	N	K191	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Ubiquitination	N	K192	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Phosphorylation	N	Y196	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Acetylation	N	K199	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K199	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine cancer		Acetylation	N	K199	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Ubiquitination	N	K199	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K199	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Cholangiocarcinoma		Phosphorylation	N	S203	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Phosphorylation	N	S203	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S203	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine cancer		Phosphorylation	N	S203	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Breast invasive carcinoma		Phosphorylation	N	T243	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Bladder urothelial carcinoma		Phosphorylation	N	S256	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S256	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K264	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Acetylation	N	K264	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K264	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K264	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Ubiquitination	N	K264	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K267	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Acetylation	N	K267	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K267	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K267	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Ubiquitination	N	K267	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S271	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Phosphorylation	N	S271	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K272	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Ubiquitination	N	K272	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Ubiquitination	N	K279	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	T281	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Phosphorylation	N	T281	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Phosphorylation	C	T288	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	T288	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Phosphorylation	N	T288	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K291	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Acetylation	N	K291	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Acetylation	N	K291	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K291	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Skin cutaneous melanoma		Ubiquitination	N	K291	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Ubiquitination	N	K291	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K297	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Inborn genetic diseases		Phosphorylation	N	S305	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S305	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S320	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	S321	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Ubiquitination	N	K322	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K322	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Rectum adenocarcinoma		Ubiquitination	N	K322	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Ubiquitination	N	K322	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Ubiquitination	N	K322	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Ubiquitination	N	K322	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Acetylation	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Rectum adenocarcinoma		Acetylation	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Acetylation	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Acetylation	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Acetylation	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Ubiquitination	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Rectum adenocarcinoma		Ubiquitination	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Ubiquitination	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Ubiquitination	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Ubiquitination	N	K323	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Kidney renal clear cell carcinoma		Phosphorylation	N	Y324	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	Y324	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Rectum adenocarcinoma		Phosphorylation	N	Y324	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Stomach adenocarcinoma		Phosphorylation	N	Y324	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Phosphorylation	N	Y324	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Phosphorylation	N	Y324	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Lung adenocarcinoma		Ubiquitination	N	K332	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Ubiquitination	N	K332	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterus adenocarcinoma		Ubiquitination	N	K332	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Brain lower grade glioma		Acetylation	N	K353	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Lung adenocarcinoma		Acetylation	N	K353	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Brain lower grade glioma		Ubiquitination	N	K353	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Lung adenocarcinoma		Ubiquitination	N	K353	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Brain lower grade glioma		Acetylation	N	K361	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Lung adenocarcinoma		Acetylation	N	K361	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Brain lower grade glioma		Ubiquitination	N	K361	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Lung adenocarcinoma		Ubiquitination	N	K361	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Lung adenocarcinoma		Methylation	N	R365	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Ovarian adenocarcinoma		Phosphorylation	N	T378	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Phosphorylation	N	T378	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Phosphorylation	N	T378	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Ovarian adenocarcinoma		Acetylation	N	K382	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Acetylation	N	K382	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Acetylation	N	K382	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Ovarian adenocarcinoma		Ubiquitination	N	K382	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Phosphoglycerate kinase 1 deficiency		Ubiquitination	N	K382	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Uterine corpus endometrial carcinoma		Ubiquitination	N	K382	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Ovarian adenocarcinoma		Acetylation	N	K388	
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Ovarian adenocarcinoma		Ubiquitination	N	K388	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Skin cutaneous melanoma		Methylation	N	K5	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Skin cutaneous melanoma		Ubiquitination	N	K5	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Methylation	N	R13	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	Y49	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Ubiquitination	N	K55	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	T59	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Acetylation	N	K61	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		SUMOylation	N	K61	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Ubiquitination	N	K61	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine carcinosarcoma		Methylation	N	R80	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine carcinosarcoma		Phosphorylation	N	S83	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Phosphorylation	N	S83	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine carcinosarcoma		Acetylation	N	K84	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Acetylation	N	K84	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine carcinosarcoma		Ubiquitination	N	K84	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Ubiquitination	N	K84	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine carcinosarcoma		Acetylation	N	K86	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Acetylation	N	K86	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine carcinosarcoma		Ubiquitination	N	K86	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Ubiquitination	N	K86	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Phosphorylation	N	Y94	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Phosphorylation	N	Y94	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Phosphorylation	N	S98	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Phosphorylation	N	S98	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Phosphorylation	N	T99	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Uterine corpus endometrial carcinoma		Phosphorylation	N	T99	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Skin cutaneous melanoma		Acetylation	N	K117	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Skin cutaneous melanoma		Ubiquitination	N	K117	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Skin cutaneous melanoma		Phosphorylation	N	S122	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	Y140	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	S143	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Acetylation	N	K145	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Ubiquitination	N	K145	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	S148	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	S151	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	T153	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Bladder urothelial carcinoma		Phosphorylation	N	T154	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Hepatocellular carcinoma		Phosphorylation	N	T176	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Ovarian serous cystadenocarcinoma		Phosphorylation	N	T176	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Hepatocellular carcinoma		Phosphorylation	N	T177	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Ovarian serous cystadenocarcinoma		Phosphorylation	N	T177	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Phosphorylation	N	S210	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Phosphorylation	N	T211	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach cancer		Phosphorylation	N	T211	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Acetylation	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Acetylation	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Acetylation	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		SUMOylation	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		SUMOylation	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		SUMOylation	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Ubiquitination	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Ubiquitination	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Ubiquitination	N	K215	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Acetylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Acetylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		Acetylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Methylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Methylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		Methylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		SUMOylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		SUMOylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		SUMOylation	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Ubiquitination	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Ubiquitination	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		Ubiquitination	N	K219	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Acetylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Acetylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		Acetylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Methylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Methylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		Methylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		SUMOylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		SUMOylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		SUMOylation	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast adenocarcinoma		Ubiquitination	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Breast invasive carcinoma		Ubiquitination	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		Ubiquitination	N	K227	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Head and neck squamous cell carcinoma		Phosphorylation	N	T229	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Phosphorylation	N	T237	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Phosphorylation	N	S241	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Acetylation	N	K254	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		SUMOylation	N	K254	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Ubiquitination	N	K254	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Phosphorylation	N	Y255	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Acetylation	N	K259	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Acetylation	N	K259	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		SUMOylation	N	K259	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		SUMOylation	N	K259	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Ubiquitination	N	K259	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Ubiquitination	N	K259	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Methylation	N	K260	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Methylation	N	K260	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		SUMOylation	N	K260	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		SUMOylation	N	K260	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Acetylation	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Acetylation	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Methylation	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Methylation	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		SUMOylation	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		SUMOylation	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Ubiquitination	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Ubiquitination	N	K263	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Phosphorylation	N	S266	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Stomach adenocarcinoma		Phosphorylation	N	S266	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Lung adenocarcinoma		Ubiquitination	N	K271	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Leiomyosarcoma		Methylation	N	R323	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Sarcoma		Methylation	N	R323	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Leiomyosarcoma		Phosphorylation	N	S333	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Sarcoma		Phosphorylation	N	S333	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Leiomyosarcoma		Acetylation	N	K334	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Sarcoma		Acetylation	N	K334	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Leiomyosarcoma		Methylation	N	K334	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Sarcoma		Methylation	N	K334	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Leiomyosarcoma		Ubiquitination	N	K334	
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Sarcoma		Ubiquitination	N	K334	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Acetylation	N	S2	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Esophageal cancer		Acetylation	N	S2	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Phosphorylation	N	S2	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Acetylation	N	K5	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Ubiquitination	N	K5	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Methylation	N	R9	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Methylation	N	R9	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colorectal adenocarcinoma		Methylation	N	R9	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Phosphorylation	C	S14	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colorectal adenocarcinoma		Phosphorylation	C	S14	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Methylation	N	R15	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colorectal adenocarcinoma		Methylation	N	R15	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Phosphorylation	C	T19	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colorectal adenocarcinoma		Phosphorylation	C	T19	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Acetylation	N	K60	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Ubiquitination	N	K60	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Phosphorylation	N	S63	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Acetylation	N	K64	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Ubiquitination	N	K64	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Acetylation	N	K71	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Acetylation	N	K71	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Acetylation	N	K71	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Ubiquitination	N	K71	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Ubiquitination	N	K71	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Ubiquitination	N	K71	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Bladder urothelial carcinoma		Phosphorylation	N	T72	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Phosphorylation	N	T72	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Phosphorylation	N	T72	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Phosphorylation	N	S79	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Phosphorylation	N	S79	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Acetylation	N	K80	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Acetylation	N	K80	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Ubiquitination	N	K80	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Ubiquitination	N	K80	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Acetylation	N	K81	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Acetylation	N	K81	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Ubiquitination	N	K81	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Head and neck squamous cell carcinoma		Ubiquitination	N	K81	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lymphoid neoplasm diffuse large B-cell lymphoma		Acetylation	N	K105	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung adenocarcinoma		Phosphorylation	N	S115	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lymphoid neoplasm diffuse large B-cell lymphoma		Phosphorylation	N	S115	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung adenocarcinoma		Ubiquitination	N	K120	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Uterine corpus endometrial carcinoma		Ubiquitination	N	K120	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer		Acetylation	N	K126	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Prostate cancer		Acetylation	N	K126	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Uterine corpus endometrial carcinoma		Acetylation	N	K126	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Uterine corpus endometrial carcinoma		Ubiquitination	N	K126	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Uterine corpus endometrial carcinoma		Phosphorylation	N	Y131	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Uterine corpus endometrial carcinoma		Phosphorylation	N	S141	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Breast adenocarcinoma		Phosphorylation	N	S157	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Breast invasive carcinoma		Phosphorylation	N	S157	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S157	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Uterine corpus endometrial carcinoma		Phosphorylation	N	S157	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Ubiquitination	N	K197	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Acetylation	N	K199	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Ubiquitination	N	K199	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Acetylation	N	K202	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Ubiquitination	N	K202	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	T205	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colon adenocarcinoma		Phosphorylation	N	T205	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Acetylation	N	K221	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		SUMOylation	N	K221	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Ubiquitination	N	K221	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Glioblastoma		Phosphorylation	N	Y236	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Glioblastoma		Phosphorylation	N	T237	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Glioblastoma		Acetylation	N	K239	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung cancer		Phosphorylation	N	S254	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Phosphorylation	N	S254	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Uterine cancer		Phosphorylation	N	S254	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Acetylation	N	K256	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach cancer		Acetylation	N	K256	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Methylation	N	K256	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		SUMOylation	N	K256	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Ubiquitination	N	K256	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Skin cutaneous melanoma		Acetylation	N	K262	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Acetylation	N	K262	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Skin cutaneous melanoma		SUMOylation	N	K262	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		SUMOylation	N	K262	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Skin cutaneous melanoma		Ubiquitination	N	K262	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Ubiquitination	N	K262	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Skin cutaneous melanoma		Phosphorylation	N	S263	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Stomach adenocarcinoma		Phosphorylation	N	S263	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Skin cutaneous melanoma		Phosphorylation	N	Y270	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Methylation	N	R412	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S419	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung adenocarcinoma		Phosphorylation	N	S419	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Acetylation	N	K420	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung adenocarcinoma		Acetylation	N	K420	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K420	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung adenocarcinoma		Ubiquitination	N	K420	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung adenocarcinoma		Acetylation	N	K422	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung adenocarcinoma		Ubiquitination	N	K422	
P09622	1738	DLD GCSL LAD PHE3	Colon adenocarcinoma		Acetylation	N	K66	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Acetylation	N	K66	
P09622	1738	DLD GCSL LAD PHE3	Colon adenocarcinoma		Methylation	N	K66	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Methylation	N	K66	
P09622	1738	DLD GCSL LAD PHE3	Dihydrolipoamide dehydrogenase deficiency		Acetylation	N	K72	
P09622	1738	DLD GCSL LAD PHE3	Head and neck squamous cell carcinoma		Acetylation	N	K104	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Acetylation	N	K104	
P09622	1738	DLD GCSL LAD PHE3	Head and neck squamous cell carcinoma		Ubiquitination	N	K104	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Ubiquitination	N	K104	
P09622	1738	DLD GCSL LAD PHE3	Head and neck squamous cell carcinoma		Methylation	N	R109	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Methylation	N	R109	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Acetylation	N	K122	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Ubiquitination	N	K127	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Ubiquitination	N	K127	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Ubiquitination	N	K132	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Phosphorylation	N	T135	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Ubiquitination	N	K159	
P09622	1738	DLD GCSL LAD PHE3	Dihydrolipoamide dehydrogenase deficiency		Phosphorylation	N	S230	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Acetylation	N	K267	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Acetylation	N	K267	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Ubiquitination	N	K267	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Ubiquitination	N	K267	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Phosphorylation	N	T276	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Ubiquitination	N	K277	
P09622	1738	DLD GCSL LAD PHE3	Bladder urothelial carcinoma		Phosphorylation	N	S297	
P09622	1738	DLD GCSL LAD PHE3	Hepatocellular carcinoma		Phosphorylation	N	S297	
P09622	1738	DLD GCSL LAD PHE3	Bladder urothelial carcinoma		Acetylation	N	K320	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Acetylation	N	K320	
P09622	1738	DLD GCSL LAD PHE3	Bladder urothelial carcinoma		Ubiquitination	N	K320	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Ubiquitination	N	K320	
P09622	1738	DLD GCSL LAD PHE3	Lung adenocarcinoma		Acetylation	N	K410	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Acetylation	N	K410	
P09622	1738	DLD GCSL LAD PHE3	Lung adenocarcinoma		Ubiquitination	N	K410	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Ubiquitination	N	K410	
P09622	1738	DLD GCSL LAD PHE3	Lung adenocarcinoma		Acetylation	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Lung cancer		Acetylation	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Acetylation	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Uterine corpus endometrial carcinoma		Acetylation	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Uterus adenocarcinoma		Acetylation	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Lung adenocarcinoma		Ubiquitination	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Ubiquitination	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Uterine corpus endometrial carcinoma		Ubiquitination	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Uterus adenocarcinoma		Ubiquitination	N	K417	
P09622	1738	DLD GCSL LAD PHE3	Lung adenocarcinoma		Acetylation	N	K420	
P09622	1738	DLD GCSL LAD PHE3	Uterine corpus endometrial carcinoma		Acetylation	N	K420	
P09622	1738	DLD GCSL LAD PHE3	Uterus adenocarcinoma		Acetylation	N	K420	
P09622	1738	DLD GCSL LAD PHE3	Lung adenocarcinoma		Ubiquitination	N	K420	
P09622	1738	DLD GCSL LAD PHE3	Uterine corpus endometrial carcinoma		Ubiquitination	N	K420	
P09622	1738	DLD GCSL LAD PHE3	Uterus adenocarcinoma		Ubiquitination	N	K420	
P09622	1738	DLD GCSL LAD PHE3	Bladder urothelial carcinoma		Ubiquitination	N	K430	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Ubiquitination	N	K430	
P09622	1738	DLD GCSL LAD PHE3	Bladder urothelial carcinoma		Phosphorylation	N	T435	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Phosphorylation	N	T435	
P09622	1738	DLD GCSL LAD PHE3	Skin cutaneous melanoma		Phosphorylation	N	T435	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Phosphorylation	N	T435	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Ubiquitination	N	K440	
P09622	1738	DLD GCSL LAD PHE3	Skin cutaneous melanoma		Ubiquitination	N	K440	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Ubiquitination	N	K440	
P09622	1738	DLD GCSL LAD PHE3	Hepatocellular carcinoma		Ubiquitination	N	K445	
P09622	1738	DLD GCSL LAD PHE3	Pyruvate dehydrogenase complex deficiency		Ubiquitination	N	K445	
P09622	1738	DLD GCSL LAD PHE3	Skin cutaneous melanoma		Ubiquitination	N	K445	
P09622	1738	DLD GCSL LAD PHE3	Dihydrolipoamide dehydrogenase deficiency		Phosphorylation	N	S476	
P09622	1738	DLD GCSL LAD PHE3	Lung adenocarcinoma		Phosphorylation	N	S502	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Phosphorylation	N	S502	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Phosphorylation	N	S502	
P09622	1738	DLD GCSL LAD PHE3	Uterine cancer		Phosphorylation	N	S502	
P09622	1738	DLD GCSL LAD PHE3	Maple syrup urine disease		Methylation	N	K505	
P09622	1738	DLD GCSL LAD PHE3	Stomach adenocarcinoma		Methylation	N	K505	
Q9H0A0	55226	NAT10 ALP KIAA1709	Glioblastoma multiforme		Methylation	N	R32	
Q9H0A0	55226	NAT10 ALP KIAA1709	Renal cell carcinoma		Acetylation	N	K60	
Q9H0A0	55226	NAT10 ALP KIAA1709	Uterine corpus endometrial carcinoma		Acetylation	N	K60	
Q9H0A0	55226	NAT10 ALP KIAA1709	Renal cell carcinoma		Ubiquitination	N	K61	
Q9H0A0	55226	NAT10 ALP KIAA1709	Uterine corpus endometrial carcinoma		Ubiquitination	N	K61	
Q9H0A0	55226	NAT10 ALP KIAA1709	Renal cell carcinoma		Phosphorylation	N	S67	
Q9H0A0	55226	NAT10 ALP KIAA1709	Uterine corpus endometrial carcinoma		Phosphorylation	N	S67	
Q9H0A0	55226	NAT10 ALP KIAA1709	Stomach adenocarcinoma		Phosphorylation	N	T173	
Q9H0A0	55226	NAT10 ALP KIAA1709	Bladder urothelial carcinoma		Phosphorylation	N	T223	
Q9H0A0	55226	NAT10 ALP KIAA1709	Head and neck squamous cell carcinoma		Phosphorylation	N	T223	
Q9H0A0	55226	NAT10 ALP KIAA1709	Lung adenocarcinoma		Phosphorylation	N	T223	
Q9H0A0	55226	NAT10 ALP KIAA1709	Breast invasive carcinoma		Ubiquitination	N	K239	
Q9H0A0	55226	NAT10 ALP KIAA1709	Colon adenocarcinoma		Ubiquitination	N	K256	
Q9H0A0	55226	NAT10 ALP KIAA1709	Colorectal adenocarcinoma		Ubiquitination	N	K256	
Q9H0A0	55226	NAT10 ALP KIAA1709	Lung adenocarcinoma		Phosphorylation	N	Y416	
Q9H0A0	55226	NAT10 ALP KIAA1709	Brain lower grade glioma		Acetylation	N	K426	
Q9H0A0	55226	NAT10 ALP KIAA1709	Brain lower grade glioma		Ubiquitination	N	K426	
Q9H0A0	55226	NAT10 ALP KIAA1709	Brain lower grade glioma		Phosphorylation	N	S435	
Q9H0A0	55226	NAT10 ALP KIAA1709	Hepatocellular carcinoma		Phosphorylation	N	S435	
Q9H0A0	55226	NAT10 ALP KIAA1709	Breast adenocarcinoma		Phosphorylation	N	S589	
Q9H0A0	55226	NAT10 ALP KIAA1709	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S589	
Q9H0A0	55226	NAT10 ALP KIAA1709	Hepatocellular carcinoma		Phosphorylation	N	S589	
Q9H0A0	55226	NAT10 ALP KIAA1709	Renal cell carcinoma		Phosphorylation	N	S589	
Q9H0A0	55226	NAT10 ALP KIAA1709	Skin cutaneous melanoma		Phosphorylation	N	S589	
Q9H0A0	55226	NAT10 ALP KIAA1709	Breast adenocarcinoma		Phosphorylation	N	S593	
Q9H0A0	55226	NAT10 ALP KIAA1709	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	S593	
Q9H0A0	55226	NAT10 ALP KIAA1709	Hepatocellular carcinoma		Phosphorylation	N	S593	
Q9H0A0	55226	NAT10 ALP KIAA1709	Renal cell carcinoma		Phosphorylation	N	S593	
Q9H0A0	55226	NAT10 ALP KIAA1709	Skin cutaneous melanoma		Phosphorylation	N	S593	
Q9H0A0	55226	NAT10 ALP KIAA1709	Breast adenocarcinoma		Ubiquitination	N	K599	
Q9H0A0	55226	NAT10 ALP KIAA1709	Lung adenocarcinoma		Phosphorylation	N	Y635	
Q9H0A0	55226	NAT10 ALP KIAA1709	Skin cutaneous melanoma		Phosphorylation	N	Y635	
Q9H0A0	55226	NAT10 ALP KIAA1709	Bladder urothelial carcinoma		Phosphorylation	N	T666	
Q9H0A0	55226	NAT10 ALP KIAA1709	Pancreatic adenocarcinoma		Phosphorylation	N	T666	
Q9H0A0	55226	NAT10 ALP KIAA1709	Skin cutaneous melanoma		Phosphorylation	N	T666	
Q9H0A0	55226	NAT10 ALP KIAA1709	Ovarian cancer		Phosphorylation	N	S679	
Q9H0A0	55226	NAT10 ALP KIAA1709	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Phosphorylation	N	T686	
Q9H0A0	55226	NAT10 ALP KIAA1709	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K689	
Q9H0A0	55226	NAT10 ALP KIAA1709	Colon adenocarcinoma		Phosphorylation	N	T932	
Q9H0A0	55226	NAT10 ALP KIAA1709	Breast invasive carcinoma		Ubiquitination	N	K956	
Q9H0A0	55226	NAT10 ALP KIAA1709	Breast invasive carcinoma		Phosphorylation	N	S957	
Q9H0A0	55226	NAT10 ALP KIAA1709	Breast invasive carcinoma		Phosphorylation	N	Y963	
Q9H0A0	55226	NAT10 ALP KIAA1709	Stomach adenocarcinoma		Ubiquitination	N	K978	
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Esophageal squamous cell carcinoma	tumor tissue	Deubiquitination	U		32707136
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Non-small cell lung cancer	tumor tissue	Ubiquitination	D		30471866
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Glioblastoma multiforme	M2 macrophages	Threonine phosphorylation	U	T243	30029001
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Lung adenocarcinoma	LUAD tissues	Succinylation	U	K323	38256128
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Hepatocellular carcinoma	tumor tissue	Polyubiquitination	P	K139	37450367
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Hepatocellular carcinoma	tumor tissue	Serine phosphorylation	P	S151	37450367
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Liver cancer	tumor tissue	Arginine methylation	D	R234	30232003
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Cancer	CD8+T cells	Serotonylation	D	Q262	38215751
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung cancer	lung cancer tissues	Arginine methylation	U	R9	36815049
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Lung cancer	lung cancer tissues	Arginine methylation	U	R372	36815049
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colorectal cancer	CRC tissues	Crotonylation	U	K420	34547627
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Colorectal cancer	CRC tissues	Decrotonylation	D	K420	34547627
P09622	1738	DLD GCSL LAD PHE3	Cardiac hypertrophy	heart tissue	2-Hydroxyisobutyrylation	U	K440	36572672
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Diabetes		Demalonylation	D	K184	26073543
P00352	216	ALDH1A1 ALDC ALDH1 PUMB1	Bladder cancer	bladder cancer tissues	2-Hydroxyisobutyrylation	D	K260	37867947
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Oral adenoid cystic carcinoma	OACC-tumor tissues	2-Hydroxyisobutyrylation	U	K323	37741973
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Oral adenoid cystic carcinoma	OACC-tumor tissues	2-Hydroxyisobutyrylation	U	K254	37741973
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K28	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K103	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K105	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K221	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Oral adenoid cystic carcinoma	OACC-tumor tissues	2-Hydroxyisobutyrylation	U	K228	37741973
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K239	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K256	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K262	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Liver cancer	hepatoma cells	2-Hydroxyisobutyrylation	U	K281	34000466
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K285	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	pancreatic ductal adenocarcinoma cells	Acetylation	U	K330	20433201
P06733	2023	ENO1 ENO1L1 MBPB1 MPB1	Pancreatic cancer/carcinoma/adenocarcinoma	tumor tissue	Serine phosphorylation	U	S419	20455595
Q9H0A0	55226	NAT10 ALP KIAA1709	Esophageal squamous cell carcinoma	ESCC tissues	2-Hydroxyisobutyrylation	U	K823	36882514
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Esophageal carcinoma		Serine phosphorylation	U	S203	31578148
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Liver cancer		Acetylation	U	K323	27774669
P00558	5230	PGK1 PGKA MIG10 OK/SW-cl.110	Glioblastoma multiforme		Acetylation	U	K388	28238651
P04406	2597	GAPDH GAPD CDABP0047 OK/SW-cl.12	Inflammation		Malonylation	U	K213	30659183
